RecruitingNCT05694624

Investigations Into Sepsis-associated Acute Kidney Injury

Investigations Into the Mechanisms for Bioenergetic Failure in Sepsis-associated Acute Kidney Injury


Sponsor

University Hospital of North Norway

Enrollment

20 participants

Start Date

Aug 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In this study the investigators would like to study systemic and regional disturbances in patients with sepsis-associated acute kidney injury and in healthy controls undergoing laparoscopic abdominal surgery. Specifically study metabolic, hemodynamic and oxygen transport variables.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Para Aminohippurate for people with acute kidney injury. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPara Aminohippurate

Measurements of renal plasma flow and glomerular filtration rate


Locations(1)

University Hospital of North Norway

Tromsø, Troms, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05694624


Related Trials